Toward optimizing pomalidomide therapy in MM patients

Research output: Journal article (peer-reviewed)Journal article

1 Citation (Scopus)


In this issue of Blood, Sehgal et al report on the clinical and pharmacodynamics analysis of pomalidomide dosing strategies in multiple myeloma (MM) and their impact on immune activation and cereblon targets. The particular novelty of this study lies in the direct correlation of immune effects triggered by pomalidomide with clinical responses in MM patients. Results of this study will stimulate many additional studies.

Original languageEnglish
Pages (from-to)3968-3969
Number of pages2
Issue number26
Publication statusPublished - 25 Jun 2015
Externally publishedYes


  • Angiogenesis Inhibitors/therapeutic use
  • Female
  • Humans
  • Male
  • Multiple Myeloma/drug therapy
  • Thalidomide/analogs & derivatives


Dive into the research topics of 'Toward optimizing pomalidomide therapy in MM patients'. Together they form a unique fingerprint.

Cite this